ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

ClinicalTrials.gov ID: NCT05794906

Public ClinicalTrials.gov record NCT05794906. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared With Placebo Plus ADT in Patients With High-risk Biochemical Recurrence (BCR) of Prostate Cancer

Study identification

NCT ID
NCT05794906
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
985 participants

Conditions and interventions

Interventions

  • ADT Other
  • Darolutamide (BAY1841788, Nubeqa) Drug
  • Placebo matching darolutamide Other

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2023
Primary completion
Jul 29, 2027
Completion
Mar 28, 2030
Last update posted
Apr 16, 2026

2023 – 2030

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
21
Facility City State ZIP Site status
Mayo Clinic Hospital - Phoenix - Cardiology Phoenix Arizona 85054
City of Hope - Duarte Cancer Center Duarte California 91010
USC Norris Comprehensive Cancer Center Los Angeles California 90033
Tower Urology Los Angeles California 90048
UCLA Clark Urology Center Los Angeles California 90095
UCSF Bakar Precision Cancer Medicine Building - Genitourinary San Francisco California 94143
Colorado Urology - St. Anthony Hospital Campus Lakewood Colorado 80228
Northwestern Medicine - Urology Chicago Illinois 60611
The University of Kansas Cancer Center - Richard and Annette Bloch Radiation Oncology Pavilion Kansas City Kansas 66160
Chesapeake Urology Associates - Towson Baltimore Maryland 21204
Sidney Kimmel Comprehensive Cancer Center - Johns Hopkins Baltimore Maryland 21231
Dana-Farber Cancer Institute - Oncology Department Boston Massachusetts 02215
Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit Michigan 48201
M Health Fairview Masonic Cancer Clinic - Clinics and Surgery Center Minneapolis Minnesota 55455
Washington University School of Medicine - Center for Advanced Medicine (CAM) St Louis Missouri 63110-1032
XCancer Omaha Omaha Nebraska 68130
NYU Langone Health Mineola New York 11501
Icahn School of Medicine at Mount Sinai - Oncology New York New York 10029
Alliance Urology Specialists Greensboro North Carolina 27403
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Carolina Urological Research Center Myrtle Beach South Carolina 29579
University Hospital Simmons Cancer Center Genitourinary Clinic Dallas Texas 75235
The University of Texas MD Anderson Cancer Center - Texas Medical Center Houston Texas 77030
USA Clinical Trials San Antonio Texas 78229
The Urology Place San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 201 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05794906, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05794906 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →